Zentalis reports updated DENALI trial results for azenosertib in platinum-resistant ovarian cancer, showing 6.3 months median duration of response. Updated median duration of response (mDOR) of 6.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results